# An In Silico Investigation of the Molecular Interactions between Volatile Anesthetics and Actin

**Authors:** Barbara Truglia, Nicola Carbone, Ibrahim Ghadre, Sara Vallero, Marinella Zito, Eric Adriano Zizzi, Marco Agostino Deriu, J. A. Tuszynski

PMC · DOI: 10.3390/ph17010037 · 2023-12-26

## TL;DR

This study uses computer modeling to explore how common anesthetics interact with actin, a key protein in cells, to better understand how anesthesia works at the molecular level.

## Contribution

The study investigates the molecular interactions between volatile anesthetics and actin using molecular docking simulations.

## Key findings

- Volatile anesthetics interact with actin through Van der Waals and hydrogen bonding, particularly isoflurane and sevoflurane.
- Anesthetics exhibit solvent-like behavior, suggesting a potential mechanism for their effects on cellular structures.
- The study compares anesthetic interactions with actin and tubulin, providing insights into their molecular targets.

## Abstract

Volatile anesthetics (VAs) are medicinal chemistry compounds commonly used to enable surgical procedures for patients who undergo painful treatments and can be partially or fully sedated, remaining in an unconscious state during the operation. The specific molecular mechanism of anesthesia is still an open issue, but scientific evidence supports the hypothesis of the involvement of both putative hydrophobic cavities in membrane receptors as binding pockets and interactions between anesthetics and cytoplasmic proteins. Previous studies demonstrated the binding of VAs to tubulin. Since actin is the other major component of the cytoskeleton, this study involves an investigation of its interactions with four major anesthetics: halothane, isoflurane, sevoflurane, and desflurane. Molecular docking was implemented using the Molecular Operating Environment (MOE) software (version 2022.02) and applied to a G-actin monomer, extrapolating the relative binding affinities and root-mean-square deviation (RMSD) values. A comparison with the F-actin was also made to assess if the generally accepted idea about the enhanced F-to-G-actin transformation during anesthesia is warranted. Overall, our results confirm the solvent-like behavior of anesthetics, as evidenced by Van der Waals interactions as well as the relevant hydrogen bonds formed in the case of isoflurane and sevoflurane. Also, a comparison of the interactions of anesthetics with tubulin was made. Finally, the short- and long-term effects of anesthetics are discussed for their possible impact on the occurrence of mental disorders.

## Linked entities

- **Proteins:** ACTIN (hypothetical protein), gammaTub23C (gamma-Tubulin at 23C)
- **Chemicals:** halothane (PubChem CID 3562), isoflurane (PubChem CID 3763), sevoflurane (PubChem CID 5206), desflurane (PubChem CID 42113)

## Full-text entities

- **Genes:** MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, CAMK2G (calcium/calmodulin dependent protein kinase II gamma) [NCBI Gene 818] {aka CAMK, CAMK-II, CAMKG, MRD59}, KCNK2 (potassium two pore domain channel subfamily K member 2) [NCBI Gene 3776] {aka K2p2.1, TPKC1, TREK, TREK-1, TREK1, hTREK-1c}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, CFL1 (cofilin 1) [NCBI Gene 1072] {aka CFL, HEL-S-15, cofilin}, KCNA2 (potassium voltage-gated channel subfamily A member 2) [NCBI Gene 3737] {aka DEE32, EIEE32, HBK5, HK4, HUKIV, KV1.2}, DBN1 (drebrin 1) [NCBI Gene 1627] {aka D0S117E}
- **Diseases:** pain (MESH:D010146), autism (MESH:D001321), nausea (MESH:D009325), SITE 3 (MESH:C537153), delirium (MESH:D003693), schizophrenia (MESH:D012559), memory loss (MESH:D008569), mental disorders (MESH:D001523), pneumonia (MESH:D011014), respiratory depression (MESH:D012131), injury to people or property (MESH:C000719191), Parkison's disease (MESH:D004194), neurodegenerative pathologies (MESH:D019636), SITE (OMIM:136570), Alzheimer's disease (MESH:D000544), confusion (MESH:D003221), neurological damage (MESH:D020196), toxicity (MESH:D064420), cardiovascular instability (MESH:D002318), hypertension (MESH:D006973), heart attack (MESH:D009203), SITE 1 (OMIM:167959), neuronal disorders (MESH:D009410), stroke (MESH:D020521), reduced cardiac function (MESH:D006331), cognitive activity impairment (MESH:D003072), tachycardia (MESH:D013610), decreased blood pressure (MESH:D007022)
- **Species:** Gallus gallus (bantam, species) [taxon 9031], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** N255V, A 19F, N255F, N255A, W273A
- **Cell lines:** 8D17 — Mus musculus (Mouse), Hybridoma (CVCL_J011), 8DNH — Xenopus laevis (African clawed frog), Spontaneously immortalized cell line (CVCL_4564)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10819646/full.md

---
Source: https://tomesphere.com/paper/PMC10819646